These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1894471

  • 1. The significance of complement in proliferative vitreoretinopathy.
    Grisanti S, Wiedemann P, Weller M, Heimann K, Zilles K.
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
    [Abstract] [Full Text] [Related]

  • 2. [Proliferative vitreoretinopathy. Activation of the complement system].
    Grisanti S, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb; 89(1):50-4. PubMed ID: 1533804
    [Abstract] [Full Text] [Related]

  • 3. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC.
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [Abstract] [Full Text] [Related]

  • 4. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier].
    Grisanti S, Wiedemann P, Heimann K.
    Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
    Weller M, Clausen R, Bresgen M, Heimann K, Wiedemann P.
    Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
    [Abstract] [Full Text] [Related]

  • 8. Complement and complement regulatory proteins in human tears.
    Willcox MD, Morris CA, Thakur A, Sack RA, Wickson J, Boey W.
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A preliminary study on cytokines in proliferative vitreoretinopathy].
    Li X, Huang J.
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):256-9, 18. PubMed ID: 11877201
    [Abstract] [Full Text] [Related]

  • 11. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A, Nakayama M, Fujita T, Kitajima H, Imai S, Shimizu A.
    Diagn Clin Immunol; 1987 Jul; 5(2):86-90. PubMed ID: 3497734
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
    Clausen R, Weller M, Hilgers RD, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Jul; 87(3):283-6. PubMed ID: 2376377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I, Speck U, Schild H.
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin binds C1q and activates the classical pathway of complement.
    Peake PW, Shen Y, Walther A, Charlesworth JA.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):560-5. PubMed ID: 18179772
    [Abstract] [Full Text] [Related]

  • 18. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S, O'Connor Miquel C, Lluch Hernández AM, García-Conde Bru J.
    Med Clin (Barc); 1988 Dec 10; 91(20):769-74. PubMed ID: 3266280
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA, Strauss LG, Georgi M.
    Strahlenther Onkol; 1986 Jul 10; 162(7):441-7. PubMed ID: 3488595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.